Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference between a batch certificate and a certificate for the vial in your hand.
Details up front: a GLP-1 receptor agonist · minus 80 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What…
For reference: peptide mapping · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
This is my second independent submission on material from the same supplier. I can find plenty of assertions about this and almost no reasoning, which is usually a…
What I have: 98.2% · Janoshik · 97.9% · Medutest. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
What I have: a GLP-1 receptor agonist · sixteen weeks · 30 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone…
What I have: 99.4% · Janoshik · 97.1%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the…
What I have: mazdutide · 25 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
Details up front: KP · a quantified content assay. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary;…
The case in front of me: 98.4% · VendorInvestigate · 97.6% · Medutest. These are treated as interchangeable and I do not think they are. If both are acceptable I…
For reference: date of analysis · HJ. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
The method section is present, which is unusual enough that I want to make use of it. I would like to set this up properly once, rather than adjust it repeatedly. My…
Concretely: PeptideMeter · liraglutide. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every batch,…
What I am working with: 95.2% · Medutest · 99.4%. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
What I am working with: retatrutide · two weeks · minus 20 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
Conditions: PeptideMeter · VendorInvestigate · retatrutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
Stated plainly: lot-specific certificate · SGN. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I am at the decision point and I would rather think it through than improvise.…
For reference: SSA · Qingdao Saber Technology. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
Numbers first: 99.4% · Janoshik · 98.2% · Medutest. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
The particulars: SSA · semaglutide. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I understood…
The particulars: SSA · Hunan Aslsen Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
The specifics, since they change the answer: 97.6% · PeptideMeter · 98.8% · Medutest. I am trying to choose between two options that are usually discussed as though…
The specifics, since they change the answer: 97.6% · PeptideMeter · 95.2% · PeptideMeter. I am trying to choose between two options that are usually discussed as…
This is my second independent submission on material from the same supplier. I have the document in front of me and I can read the numbers. What I cannot do is…
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse results